All In MedTech

Device Trial Radar · NCT07209358

EDX110 Randomized Control Trial for Treatment of DFUs

A Multi-Centre, Observer-Blinded, Randomized Controlled Trial of EDX110 for the Treatment of Diabetic Foot Ulcers

Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

300

Actual

Start

Oct 30, 2025

Primary completion

Mar 31, 2027

Study completion Jun 30, 2027

Sponsor

Lead sponsor
ConvaTec Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 7, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective, multi-centered, observer blinded, pre-market study, 1:1 randomized control trial, to determine if addition of EDX110 dressing system to standard of care leads to an improvement in diabetic foot ulcers healing compared to just using standard of care.

Conditions

  • Wound Heal
  • Diabetic Foot Ulcer

Interventions

  • EDX110Device

    EDX110 wound dressing system EDX110 is a dressing system comprising two layers that allows the generation of nitric oxide (NO) in situ, enables adequate moisture management and facilitates debridement

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Wound ClosureTime frame: 16 Weeks

Locations

10 sites in 2 countries. Site status is shown where the registry gives one.

  • Advanced Foot Care

    Phoenix, Arizona

  • Keck Medicine of USC

    Los Angeles, California

  • Clemente Clinical Research

    Santa Ana, California

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.